These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 25375625
1. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis. He LW, Shi R, Jiang L, Zeng Y, Ma WL, Zhou JY. PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625 [Abstract] [Full Text] [Related]
2. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies. Jiang L, Fang X, Bao Y, Zhou JY, Shen XY, Ding MH, Chen Y, Hu GH, Lu YC. PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237 [Abstract] [Full Text] [Related]
3. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis. Zhang H, Liu H, Knauss JL. Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607 [Abstract] [Full Text] [Related]
4. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis. Wu W, Liu L, Yin Z, Guan P, Li X, Zhou B. PLoS One; 2014 Oct; 9(1):e86798. PubMed ID: 24497981 [Abstract] [Full Text] [Related]
5. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis. Li Y, Liu F, Tan SQ, Wang Y, Li SW. PLoS One; 2012 Oct; 7(9):e44441. PubMed ID: 22984511 [Abstract] [Full Text] [Related]
6. Association between XRCC1 polymorphisms and glioma risk among Chinese population. Li J, Qu Q, Qu J, Luo WM, Wang SY, He YZ, Luo QS, Xu YX, Wang YF. Med Oncol; 2014 Oct; 31(10):186. PubMed ID: 25245010 [Abstract] [Full Text] [Related]
7. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis. Gu X, Sun H, Chang L, Sun R, Yang H, Zhang X, Cong X. Neural Regen Res; 2013 Sep 15; 8(26):2468-77. PubMed ID: 25206557 [Abstract] [Full Text] [Related]
8. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis. Li J, Li Z, Feng L, Guo W, Zhang S. Tumour Biol; 2013 Feb 15; 34(1):261-9. PubMed ID: 23055199 [Abstract] [Full Text] [Related]
9. Investigation of the role of XRCC1 genetic polymorphisms in the development of gliomas in a Chinese population. Fan SC, Zhou JG, Yin JZ. Genet Mol Res; 2016 Aug 26; 15(3):. PubMed ID: 27706616 [Abstract] [Full Text] [Related]
10. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis. Ma WQ, Han XQ, Wang X, Wang Y, Zhu Y, Liu NF. PLoS One; 2016 Aug 26; 11(11):e0166961. PubMed ID: 27870881 [Abstract] [Full Text] [Related]
11. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis. Xie T, Wang ZG, Zhang JL, Liu H. World J Gastroenterol; 2012 Aug 21; 18(31):4207-14. PubMed ID: 22919255 [Abstract] [Full Text] [Related]
12. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis. Du Y, Han LY, Li DD, Liu H, Gao YH, Sun DJ. Asian Pac J Cancer Prev; 2013 Aug 21; 14(9):5483-7. PubMed ID: 24175846 [Abstract] [Full Text] [Related]
13. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis. Wang R, Hu X, Zhou Y, Feng Q, Su L, Long J, Wei B. Leuk Lymphoma; 2013 Jan 21; 54(1):153-9. PubMed ID: 22712837 [Abstract] [Full Text] [Related]
14. XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies. Dai L, Wang K, Zhang J, Lv Q, Wu X, Wang Y. Int J Cancer; 2009 Sep 01; 125(5):1102-9. PubMed ID: 19444915 [Abstract] [Full Text] [Related]
15. XRCC1 polymorphisms and risk of nasopharyngeal carcinoma: a meta-analysis. Huang GL, Guo HQ, Yu CY, Liu XY, Li BB, Wu JJ, He ZW. Asian Pac J Cancer Prev; 2011 Sep 01; 12(9):2329-33. PubMed ID: 22296379 [Abstract] [Full Text] [Related]
16. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision. Zhao DY, Cheng L, Yu J, Shen H. Cancer Biomark; 2014 Sep 01; 14(6):449-56. PubMed ID: 25335737 [Abstract] [Full Text] [Related]
17. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis. Zeng FR, Ling Y, Yang J, Tian XC, Yang X, Luo RC. Tumour Biol; 2013 Feb 01; 34(1):555-63. PubMed ID: 23188703 [Abstract] [Full Text] [Related]
18. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis. Wei B, Zhou Y, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, Hu Q, Wang Q, Wang Z, Yan Z. Prostate Cancer Prostatic Dis; 2011 Sep 01; 14(3):225-31. PubMed ID: 21647176 [Abstract] [Full Text] [Related]
19. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis. Li S, Deng Y, You JP, Chen ZP, Peng QL, Huang XM, Lu QH, Huang XL, Zhao JM, Qin X. Dig Dis Sci; 2013 Jul 01; 58(7):1880-90. PubMed ID: 23543084 [Abstract] [Full Text] [Related]
20. Association between the XRCC1 Arg194Trp polymorphism and glioma risk: an updated meta-analysis. Xu C, Chen P, Liu W, Gu AH, Wang XR. Asian Pac J Cancer Prev; 2014 Jul 01; 15(17):7419-24. PubMed ID: 25227852 [Abstract] [Full Text] [Related] Page: [Next] [New Search]